Mark Johnson to Glycoproteins
This is a "connection" page, showing publications Mark Johnson has written about Glycoproteins.
Connection Strength
0.300
-
Johnson MD, Kim HR, Chesler L, Tsao-Wu G, Bouck N, Polverini PJ. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol. 1994 Jul; 160(1):194-202.
Score: 0.105
-
Jiang X, Xing H, Kim TM, Jung Y, Huang W, Yang HW, Song S, Park PJ, Carroll RS, Johnson MD. Numb regulates glioma stem cell fate and growth by altering epidermal growth factor receptor and Skp1-Cullin-F-box ubiquitin ligase activity. Stem Cells. 2012 Jul; 30(7):1313-26.
Score: 0.092
-
Johnson MD, Gray ME, Carpenter G, Pepinsky RB, Sundell H, Stahlman MT. Ontogeny of epidermal growth factor receptor/kinase and of lipocortin-1 in the ovine lung. Pediatr Res. 1989 May; 25(5):535-41.
Score: 0.074
-
Kawamata H, Kawai K, Kameyama S, Johnson MD, Stetler-Stevenson WG, Oyasu R. Over-expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma. Int J Cancer. 1995 Nov 27; 63(5):680-7.
Score: 0.029